1-Piperazine carboxamide derivatives, their preparation and their use in pharmaceutical compositions
申请人:AB Ferrosan
公开号:EP0136274A1
公开(公告)日:1985-04-03
1-piperazinecarboxamide derivatives are described which have the formula (I)
wherein R, is a member selected from hydrogen, halogen or trifluoromethyl;
wherein X is selected from:
wherein R2 and R3 are the same or different and selected from hydrogen or lower alkyl;
wherein Z ist either oxygen or sulfur;
wherein Y is -NR4R5, where R4 and R, are the same or different and selected from hydrogen, alkyl, alkenyl, cycloalkyl, aryl, aryl-(lower alkyl), or R. and R5 may together with the N-atom form a 5- or 6- or 7-membered satured ring, where one of the carbon atoms may be exchanged for O, NR8 or NCOR8;
wherein R6 and R7 are the same or different and selected from hydrogen or lower alkyl;
wherein R8 is lower alkyl or lower alkenyl;
with the proviso that when X is > CO, then R4 is hydrogen and
R, is different from hydrogen.
Pharmaceutical compositions containing said 1-piperazinecarboxamide derivates are also described.
The derivatives are useful in treating mental disorders and/or aggression in man and in treating aggression in animals and for calming animals.
Different processes for preparing the derivatives are also described.
所述 1-哌嗪甲酰胺衍生物具有式 (I)
其中 R 是选自氢、卤素或三氟甲基的成员;
其中 X 选自
其中 R2 和 R3 相同或不同,选自氢或低级烷基;
其中 Z 是氧或硫;
其中Y为-NR4R5,其中R4和R相同或不同,选自氢、烷基、烯基、环烷基、芳基、芳基-(低级烷基),或R.和R5可与N原子一起形成5-或6-或7-元对称环,其中一个碳原子可交换为O、NR8或NCOR8;
其中 R6 和 R7 相同或不同,且选自氢或低级烷基;
其中 R8 为低级烷基或低级烯基;
但当 X > CO 时,R4 为氢,R, 与氢不同。
R,不同于氢。
还描述了含有所述 1-哌嗪甲酰胺衍生物的药物组合物。
这些衍生物可用于治疗人的精神障碍和/或攻击行为,也可用于治疗动物的攻击行为和安抚动物。
还描述了制备这些衍生物的不同工艺。